Lupin share price gains on USFDA approval for nasal spray
Lupin has received approval from the United States Food and Drug Administration (USFDA) for its abbreviated new drug application for Cyanocobalamin Nasal Spray.
Lupin has received approval from the United States Food and Drug Administration (USFDA) for its abbreviated new drug application for Cyanocobalamin Nasal Spray. Lupin has received approval from the United States Food and Drug Administration (USFDA) for its abbreviated new drug application for Cyanocobalamin Nasal Spray. Moneycontrol Latest News Read More
Lupin has received approval from the United States Food and Drug Administration (USFDA) for its abbreviated new drug application for Cyanocobalamin Nasal Spray.